
Molecular Psychiatry (2008) 13, 531–543
Eleven single-nucleotide polymorphisms (SNPs) spanning OPRD1 were examined in 1063 European Americans (EAs) (620 cases with substance dependence (SD), including 557 with alcohol dependence (AD), 225 with cocaine dependence (CD) and 111 with opioid dependence (OD), and 443 controls).
Nominally significant associations (P<0.05) class="u">GCAACT, which harbors G80T G-allele and C921T C-allele, was significantly associated with AD (



Logistic regression analyses, with sex and age being considered, demonstrated that this haplotype had a risk effect on AD (P=0.03,


Although no significant differences in allele, genotype or haplotype frequency distributions were seen between cases and controls, a specific OPRK1 haplotype, GGCTTCT, was significantly associated with AD (

Logistic regression analyses also revealed its risk effect on AD (P=0.009,

Taken together, our findings supported a positive association between OPRD1 variants and SD, and a positive haplotypic association between OPRK1 and AD in EAs.
Read Full Abstract
Request Reprint E-Mail: joel.gelernter@yale.edu
____________________________________________________________